Regulator of G protein signaling (RGS) proteins modulate G protein signaling by acting as GTPase-activating proteins for G protein a subunits. RGS7 belongs to a subfamily of RGS proteins that exist as dimers with the G protein b 5 subunit. In this report, we addressed the mechanisms of plasma membrane is a complex process requiring at least RGS domain-mediated interaction with a o and RGS7 palmitoylation.
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Introduction
Heterotrimeric G proteins, composed of a and bg subunits, function as a molecular switches, relaying extracellular stimuli to cytoplasmic signaling pathways. Nucleotide exchange of GTP for GDP on the a subunit sets off a signaling cascade, whereas hydrolysis of the a-bound GTP turns off the signaling. A group of proteins called regulators of G protein signaling (RGS) accelerates this GTP hydrolysis and thus modulates the duration of the signal transduction. Over 20 subtypes of the RGS proteins have been identified and are commonly divided into six groups (Hollinger and Hepler, 2002) .
RGS7 belongs to the R7 subfamily of the RGS proteins that contain a domain called the G gamma-like (GGL) domain (Sondek and Siderovski, 2001; . Through this unique domain RGS7 interacts with the G protein b 5 subunit which deviates significantly from the other four b subunits (Snow et al., 1998) . Native b 5 RGS7 complexes have been isolated from brain extracts (Witherow et al., 2000; , and copurification experiments suggest that RGS7 always exists as a heterodimer with b 5 (Witherow et al., 2000) . One critical role for the interaction of RGS7 and b 5 is to mutually stabilize each other. Efficient expression of RGS7 in COS-7 cells depends on co-expression of b 5 and vice versa (Snow et al., 1999; Witherow et al., 2000) , and, moreover, loss of b 5 in a mouse knockout causes the complete loss of detectable RGS7 protein in retina and brain extracts (Chen et al., 2003) .
Less well understood is the physiological role for b 5 RGS7, and specifically which G protein a subunits interact with and are regulated by b 5 RGS7. In vitro GAP assays have demonstrated that b 5 RGS7 acts almost exclusively on a o , and not a i or a q (Hooks et al., 2003; Posner et al., 1999) . In contrast, b 5 RGS7 appears to show less a subunit selectivity in various cell systems. For example, This article has not been copyedited and formatted. The final version may differ from this version. (Shuey et al., 1998) , suggesting interaction with both a o and a q in cells. A recent report demonstrated fluorescence resonance energy transfer (FRET) between CFP-tagged a q and YFP-tagged RGS7 in transfected cells, indicating a direct protein-protein interaction between a q and b 5 RGS7 . Interestingly, no FRET was observed between a o and b 5 RGS7 in those studies . A difficulty in examining b 5 RGS7 interactions with a subunits has been the inability to detect stable ab 5 RGS7 complexes using either purified proteins or employing co-immunoprecipitation techniques. This is in striking contrast to other RGS proteins for which it is relatively easy to demonstrate interactions with particular activated a subunits.
To interact with G protein a subunits, RGS proteins are likely to be targeted to plasma membranes (PM). Previous work has demonstrated that b 5 RGS7 is detected in both cytosolic and membrane fractions of brain extracts and cultured cells (Rose et al., 2000; Witherow et al., 2000; Zhang et al., 2001) , and a substantial amount of b 5 RGS7 was detected in a nuclear fraction (Zhang et al., 2001) . Immunofluorescence microscopy of endogenous b 5 RGS7 in PC12 cells or overexpressed b 5 RGS7 in PC12 or HEK293 cells indicated a predominantly cytoplasmic distribution, with little or no b 5 RGS7 at the PM, along with some nuclear localization (Rojkova et al., 2003; Zhang et al., 2001 (Rose et al., 2000) , suggesting that this covalent modification could facilitate membrane binding of b 5 RGS7.
In this report, we examined whether G protein a subunits could promote PM localization and palmitoylation of b 5 RGS7. We demonstrate that expression of a o , but not a q , promotes a redistribution of b 5 RGS7 from the cytoplasm to PM.
An analysis of a o mutants suggests that the GTP-bound active form, rather than the GDP-bound form, of a o preferentially induces PM targeting of b 5 RGS7. In addition, we demonstrate that a o promotes palmitoylation of RGS7, and our results suggest that Cys 133 of RGS7 is a site of palmitoylation.
This article has not been copyedited and formatted. The final version may differ from this version. 
Materials and Methods
Cell Culture HEK293 and COS7 cells were obtained from the American Type Culture Collection (Manassas, VA) and grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and maintained at 37 °C in a 95% air, 5% CO 2 -humidified atmosphere.
Expression Vectors pcDNA3.1 encoding a o or 3xHA-tagged human RGS7 (S1 or S2) was purchased from the Guthrie cDNA Resource Center (Sayre, PA, http://www.cdna.org). RGS7(S2) is full length cDNA, and RGS7(S1) lacks amino acids from 76 to 128. A plasmid for myc-His tagged b 5 was provided by David P. Siderovski (University of North Carolina) a o mutants, a o G2A, (a o C3S), a o R179C, a o G184S, and a o G204A were created using QuickChange sitedirected mutagenesis kit (Stratagene, La Jolla, CA). So were 3xHA-tagged RGS7C120S, RGS7C133S, and RGS7C206S. The deletion mutants RGS7D17-75 and RGS7D17-112 were generated by sequential PCR amplification using pcDNA3.1-RGS7(S2) as a template, and then subcloned into pcDNA3.1 as a KpnI-XhoI fragment.
Transfection Unless otherwise noted, cells were seeded 1 day before transfection. An indicated amount of DNA constructs was transfected into cells using FuGene 6 (Roche, Indianapolis, IN).
Immunofluorescence Microscopy Cells were fixed with 3.7% formaldehyde in phosphate-buffered saline (PBS) for 15 min and permeabilized by incubation in blocking buffer (2.5% nonfat milk and 1% Triton X-100 in TBS) for 20 min. Cells were then incubated with primary antibodies indicated in blocking buffer for 1 h. Cell Fractionation Assay Soluble and particulate fractions were isolated as described previously (Evanko et al., 2000; Takida and Wedegaertner, 2003) .
Densitometric quantitation of relative amounts in soluble versus particulate fractions was performed using a Kodak DC40 imaging system. immunoblotting using an anti-HA monoclonal antibody. COS-7 cells were used for palmitoylation rather than HEK293 cells because we routinely observe better palmitate labeling of proteins using COS-7 cells (Evanko et al., 2000) . (Rose et al., 2000; , and a o is lacking from HEK293 cells (Wang et al., 1999) . Thus, this cell line facilitates studies independently of endogenous counterparts. b 5 and RGS7 were expressed in HEK293 cells, and then localization of the complex was visualized using an anti-HA monoclonal antibody to detect HA-tagged RGS7. Next, we considered the possibility that the failure of a q to promote PM localization of b 5 RGS7 (Figure 1 ) was due to a requirement for the a subunit to be sufficiently activated. Thus, we tested the ability of the constitutively active mutant a q R183C to affect localization of b 5 RGS7. As was the case with a q , a q R183C failed to promote PM localization of b 5 RGS7 (Figure 2) . When coexpressed with a q R183C, b 5 RGS7 remained in the cytoplasm of cells (Figure 2A q-t) and was found predominantly in the soluble fraction ( Figure 2B lanes 11 and   12) . These results confirm that a q , in contrast to a o , is not effective at promoting PM localization of b 5 RGS7. (Figure 3 upper panel lanes 3 and 4) . Expression of RGS7 was confirmed by Western blotting (Figure 3 lower panel) .
Palmitoylation assay
Materials
The site(s) of palmitoylation on RGS7 have not been identified, but three cysteine residues that could serve as potential palmitoylation sites exist in the region between the DEP and GGL domains (Rose et al., 2000) . We thus replaced each of those cysteines with serine to create the RGS7 mutants Figure 4B lanes 1 and 2) although the portion of RGS7C133S in the particulate was significantly reduced compared to wild type RGS7 when co-expressed with a o ( Figure 1B lanes 3 and 4) . On the other hand, comprises amino acids 17 to 112 (Wong et al., 2000) . RGS7D17-75, a deletion of the N-terminal portion of the DEP domain, and RGS7D17-112, a deletion of the entire DEP domain, were expressed together with b 5 and a o , but RGS7D17-75 and RGS7D17-112 protein was almost undetectable, as assessed by Western blotting ( Figure 5A lanes 2 and 3) . RGS7D76-128, which lacks the C-terminal portion of the DEP domain and additional flanking residues, displayed a substantially greater level of expression, although slightly reduced compared to wild type RGS7 ( Figure 5A lanes 1 and 4) . Importantly, b 5 RGS7D76-128 was refractory to a o -promoted PM localization (Figure 5B a) ; it remained in the cytoplasm, implying that the deleted region is important in a o -mediated PM localization of the complex. These studies are thus the first to demonstrate regulated PM localization and palmitoylation of RGS7.
The preferred G protein a subunit target of b 5 RGS7 remains controversial.
In GAP assays using purified proteins, b 5 RGS7 is highly selective for a o and exhibits no GAP activity on a q (Hooks et al., 2003; Posner et al., 1999) . expressed. An explanation for these seemingly contradictory results is not clear.
Interestingly, stable complexes between purified b 5 RGS7 and a o , either GDP-or GDP-AlF 4 --bound, cannot be detected (Posner et al., 1999) , and coimmunoprecipitation and pull down approaches from cell lysates have likewise failed to isolate a o or a q bound to b 5 RGS7 (data not shown) (Witherow et al., 2000) . It appears as if the binding of b 5 RGS7 to a o is relatively weak compared to other RGS/Ga pairs (Posner et al., 1999) , and thus the PM recruitment of Palmitoylation has been identified in several RGS proteins and in some it has been demonstrated to influence their GAP activity. Palmitoylation of RGS4 was shown to inhibit its GAP activity toward a z (Tu et al., 1999) while palmitoylation of RGS16 increased GAP function (Osterhout et al., 2003) . Hepler and colleagues showed that, when purified from Sf9 cells, membrane-bound RGS7, which is palmitoylated, and cytosolic, non-palmitoylated RGS7 equipotently stimulated the GTPase activity of a o , suggesting that palmitoylation has no effect on RGS7's GAP activity (Rose et al., 2000) . Thus, for RGS7, a primary function of palmitoylation is probably to facilitate PM targeting of
Despite the recent breakthrough in identification of bona fide palmitoyltransferases in yeast (Linder and Deschenes, 2003; Linder and Deschenes, 2004; Lobo et al., 2002) , molecular mechanisms underlying palmitoylation in mammalian cells are still unclear. We have found that mutants of the small GTPase Sar1, which are known to inhibit vesicle transport between ER and Golgi along the exocytic pathway, had no effect on a o -mediated membrane localization of b 5 RGS7 (data not shown). Thus, our findings suggest creates an unstable protein, and, moreover, these deletion experiments raise the possibility that amino acids 112-128 could be a critical region for both stability and PM localization of RGS7. A recent report proposed that DEP domains influence subcellular targeting by interacting with SNARE or SNARE-like proteins, and R9AP, which interacts with the DEP domain of RGS9, appears to have a SNARE-like domain (Martemyanov et al., 2003b) . In light of this proposal it is particularly interesting that another recent report used two-hybrid studies to identify snapin, a SNARE complex protein, as a protein that interacts with the N- 
